As on Thursday, X4 Pharmaceuticals Inc (NASDAQ: XFOR) started slowly as it slid -3.95% to $0.48, before settling in for the price of $0.50 at the close. Taking a more long-term approach, XFOR posted a 52-week range of $0.47-$1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -20.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 73.95%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 80.70%. This publicly-traded company’s shares outstanding now amounts to $167.43 million, simultaneously with a float of $117.19 million. The organization now has a market capitalization sitting at $81.64 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6398, while the 200-day Moving Average is $0.8726.
X4 Pharmaceuticals Inc (XFOR) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. X4 Pharmaceuticals Inc’s current insider ownership accounts for 30.45%, in contrast to 38.61% institutional ownership. According to the most recent insider trade that took place on Oct 15 ’24, this organization’s President and CEO sold 31,897 shares at the rate of 0.56, making the entire transaction reach 17,926 in total value, affecting insider ownership by 1,025,816.
X4 Pharmaceuticals Inc (XFOR) Earnings and Revenue Records
X4 Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 80.70% and is forecasted to reach -0.46 in the upcoming year.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
Let’s observe the current performance indicators for X4 Pharmaceuticals Inc (XFOR). It’s Quick Ratio in the last reported quarter now stands at 6.04. The Stock has managed to achieve an average true range (ATR) of 0.04. Alongside those numbers, its PE Ratio stands at $5.66, and its Beta score is 0.37. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 145.78.
In the same vein, XFOR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.09, a figure that is expected to reach -0.17 in the next quarter, and analysts are predicting that it will be -0.46 at the market close of one year from today.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
Through scrutinizing the latest numbers posted by the [X4 Pharmaceuticals Inc, XFOR], it can be observed that its last 5-days Average volume of 1.06 million was lower the volume of 2.08 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 19.07% While, its Average True Range was 0.0416.
Raw Stochastic average of X4 Pharmaceuticals Inc (XFOR) in the period of the previous 100 days is set at 1.88%, which indicates a major fall in contrast to 7.38% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 87.95% that was lower than 98.15% volatility it exhibited in the past 100-days period.
